Create Alert
Watchlist

Glenmark Pharmaceuticals

0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
1Y
3Y
5Y
All

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Analyst Estimates

50%
Buy
21%
Hold
50%
Sell
29%
Aggregated by Refinitiv from 14 Analysts

Fundamentals

Market Cap₹25,691Cr
ROE6.48%
P/E Ratio(TTM)0.00
EPS(TTM)-25.22
P/B Ratio2.75
Dividend Yield0.27%
Industry P/E36.55
Book Value330.55
Debt to Equity0.56
Face Value1
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Glenmark Pharma

Glenmark Pharmaceuticals Limited is an India-based global pharmaceutical company. The Company is focused on building a global formulation business with branded, generics and over the counter (OTC) segments in the therapy areas of dermatology, respiratory and oncology. The Company also has a regional/country-specific presence in other therapeutic areas like diabetes, cardiovascular and oral contraceptives. Its product portfolio includes topical products, liquids, respiratory MDI/DPI, complex injectables and biologics, and oral solids. The Company has a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand, Tiogiva in the United Kingdom and Tavulus in Spain, for the treatment of chronic obstructive pulmonary disease. Ryaltris, the Company's first branded specialty product globally, is a fixed dose combination nasal spray that combines an antihistamine (Olopatadine) with a steroid (Mometasone Furoate) for treatment of allergic rhinitis.;
Parent OrganisationGlenmark Pharmaceuticals Limited
Founded1977
Managing DirectorMr. Glenn Saldanha
NSE SymbolGLENMARK

Shareholding Pattern

Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Promoters
46.65%
Foreign Institutions
23.71%
Retail And Others
19.17%
Mutual Funds
8.59%
Other Domestic Institutions
1.88%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Sun Pharmaceutical Industries
NA
(0.00%)
42.38
Cipla
NA
(0.00%)
32.14
Dr Reddy's Laboratories
NA
(0.00%)
20.51
Zydus Lifesciences
NA
(0.00%)
31.75
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.7.6
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ

ABOUT GROWW